Madrigal Pharmaceuticals, Inc.
IT ˙ BIT ˙ US5588681057
412,50 € 0,00 (0,00%)
2026-06-04
AKTIENPREIS
SecurityIT:1MDGL / Madrigal Pharmaceuticals, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership25,589 shares
Latest Disclosed Value $ 13,395,073
Citigroup Inc ownership in 1MDGL / Madrigal Pharmaceuticals, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 25,589 shares of Madrigal Pharmaceuticals, Inc. (IT:1MDGL) valued at $11,366,634 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 23,327 shares of Madrigal Pharmaceuticals, Inc.. This represents a change in shares of 9.70% during the quarter. The current value of the position is $10,555,462 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (1MDGL) in the form of stock options. The firm currently holds call options representing 9,000 of underlying shares valued at $4,711,230 USD and put options representing 30,000 of underlying shares valued at $15,704,100 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IT:1MDGL / Madrigal Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 25,589 2,262 9.70 13,395 -1.39 0.0029
2026-02-13 2025-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 23,327 13,679 141.78 13,584 206.98 0.0060
2025-11-10 2025-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 9,648 -8,835 -47.80 4,425 -20.88 0.0020
2025-08-11 2025-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 18,483 -28,736 -60.86 5,594 -64.24 0.0027
2025-05-12 2025-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 47,219 -51,019 -51.93 15,640 -48.40 0.0080
2025-02-12 2024-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 98,238 69,617 243.24 30,313 399.14 0.0180
2024-11-12 2024-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 28,621 12,559 78.19 6,074 34.99 0.0035
2024-08-12 2024-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 16,062 -16,728 -51.02 4,500 -48.62 0.0029
2024-05-10 2024-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 32,790 11,467 53.78 8,756 77.50 0.0058
2024-02-09 2023-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 21,323 -961 -4.31 4,934 51.60 0.0035
2023-12-06 2023-09-30 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 22,284 6,611 42.18 3,254 -10.11 0.0024
2023-11-09 2023-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 22,284 6,611 3,254 0.0010
2023-08-10 2023-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 15,673 -7,740 -33.06 3,620 -36.18 0.0024
2023-05-11 2023-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 23,413 -23,136 -49.70 5,672 -58.02 0.0040
2023-02-09 2022-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 46,549 -13,698 -22.74 13,511 245.08 0.0108
2022-11-10 2022-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 60,247 27,931 86.43 3,915 69.26 0.0028
2022-08-10 2022-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 32,316 24,268 301.54 2,313 192.78 0.0017
2022-05-12 2022-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 8,048 -22,652 -73.79 790 -69.64 0.0005
2022-02-10 2021-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 30,700 -7,093 -18.77 2,602 -13.73 0.0014
2021-11-10 2021-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 37,793 -160,808 -80.97 3,016 -84.41 0.0018
2021-08-10 2021-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 198,601 163,308 462.72 19,346 368.65 0.0116
2021-05-13 2021-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 35,293 32,988 1,431.15 4,128 1,512.50 0.0027
2021-02-11 2020-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 2,305 1,573 214.89 256 194.25 0.0002
2020-11-12 2020-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 732 -9,292 -92.70 87 -92.34 0.0001
2020-08-12 2020-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 10,024 683 7.31 1,136 82.05 0.0009
2020-05-12 2020-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 9,341 5,721 158.04 624 89.09 0.0006
2020-02-12 2019-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 3,620 -19,938 -84.63 330 -83.75 0.0002
2019-11-08 2019-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 23,558 -19,807 -45.68 2,031 -55.32 0.0016
2019-08-12 2019-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 43,365 42,341 4,134.86 4,546 3,424.03 0.0037
2019-05-13 2019-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 1,024 -48,969 -97.95 129 -97.71 0.0001
2019-02-12 2018-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 49,993 39,851 392.93 5,635 159.44 0.0057
2018-11-13 2018-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 10,142 -53 -0.52 2,172 -23.82 0.0019
2018-08-10 2018-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 10,195 -6,243 -37.98 2,851 48.49 0.0026
2018-05-11 2018-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 16,438 14,802 904.77 1,920 1,180.00 0.0016
2018-02-12 2017-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 1,636 1,636 150 0.0001
2017-11-13 2017-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 0 -11,351 -100.00 0 -100.00
2017-08-11 2017-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 11,351 11,351 185 0.0002
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-11 2026-03-31 13F MADRIGAL PHARMACEUTICALS COM Call 9,000 0.00 4,711 -10.11 n/a n/a n/a
2026-02-13 2025-12-31 13F MADRIGAL PHARMACEUTICALS COM Call 9,000 -66.67 5,241 -57.68 n/a n/a n/a
2025-11-10 2025-09-30 13F MADRIGAL PHARMACEUTICALS COM Call 27,000 1.89 12,384 54.42 n/a n/a n/a
2025-08-11 2025-06-30 13F MADRIGAL PHARMACEUTICALS COM Call 26,500 -33.75 8,020 -39.47 n/a n/a n/a
2025-05-12 2025-03-31 13F MADRIGAL PHARMACEUTICALS COM Call 40,000 365.12 13,249 399.40 n/a n/a n/a
2025-02-12 2024-12-31 13F MADRIGAL PHARMACEUTICALS COM Call 8,600 -92.37 2,654 -88.91 n/a n/a n/a
2024-11-12 2024-09-30 13F MADRIGAL PHARMACEUTICALS COM Call 112,700 80.03 23,917 36.37 n/a n/a n/a
2024-08-12 2024-06-30 13F MADRIGAL PHARMACEUTICALS COM Call 62,600 17,538 n/a n/a n/a
2024-05-10 2024-03-31 13F MADRIGAL PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-02-09 2023-12-31 13F MADRIGAL PHARMACEUTICALS COM Call 5,000 0.00 1,157 58.36 n/a n/a n/a
2023-12-06 2023-09-30 13F/A MADRIGAL PHARMACEUTICALS COM Call 5,000 900.00 730 534.78 n/a n/a n/a
2023-11-09 2023-09-30 13F MADRIGAL PHARMACEUTICALS COM Call 5,000 730 n/a n/a n/a
2023-08-10 2023-06-30 13F MADRIGAL PHARMACEUTICALS COM Call 500 0.00 116 -4.96 n/a n/a n/a
2023-05-11 2023-03-31 13F MADRIGAL PHARMACEUTICALS COM Call 500 -85.71 121 -88.08 n/a n/a n/a
2023-02-09 2022-12-31 13F MADRIGAL PHARMACEUTICALS COM Call 3,500 1,016 n/a n/a n/a
2022-11-10 2022-09-30 13F MADRIGAL PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-10 2022-06-30 13F MADRIGAL PHARMACEUTICALS COM Call 17,900 1,281 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-11 2026-03-31 13F MADRIGAL PHARMACEUTICALS COM Put 30,000 33.33 15,704 19.86 n/a n/a n/a
2026-02-13 2025-12-31 13F MADRIGAL PHARMACEUTICALS COM Put 22,500 -16.67 13,103 5.81 n/a n/a n/a
2025-11-10 2025-09-30 13F MADRIGAL PHARMACEUTICALS COM Put 27,000 1.89 12,384 54.42 n/a n/a n/a
2025-08-11 2025-06-30 13F MADRIGAL PHARMACEUTICALS COM Put 26,500 -33.75 8,020 -39.47 n/a n/a n/a
2025-05-12 2025-03-31 13F MADRIGAL PHARMACEUTICALS COM Put 40,000 212.50 13,249 235.50 n/a n/a n/a
2025-02-12 2024-12-31 13F MADRIGAL PHARMACEUTICALS COM Put 12,800 -29.28 3,950 2.81 n/a n/a n/a
2024-11-12 2024-09-30 13F MADRIGAL PHARMACEUTICALS COM Put 18,100 12.42 3,841 -14.83 n/a n/a n/a
2024-08-12 2024-06-30 13F MADRIGAL PHARMACEUTICALS COM Put 16,100 4,511 n/a n/a n/a
2022-11-10 2022-09-30 13F MADRIGAL PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-10 2022-06-30 13F MADRIGAL PHARMACEUTICALS COM Put 17,900 1,281 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.